首页> 外文学位 >Synthesis, separation and characterization of 2, 7 bis beta-lactams as candidate antibiotics.
【24h】

Synthesis, separation and characterization of 2, 7 bis beta-lactams as candidate antibiotics.

机译:合成,分离和表征2、7个双β-内酰胺类候选抗生素。

获取原文
获取原文并翻译 | 示例

摘要

Bis beta-lactams: 2,7-bis [3'-acetaniido-4 '-akoxyazetidin-2'-on-1'-yl]-4,5dithiasuberic acids have been researched as new beta-lactam antibiotic candidates. Significances of 2,7-bis beta-lactams are explained as (1) they have a symmetric bifunctional structural feature, therefore, their molecules have stronger affinity to enzyme substrates than other beta-lactams: (2) they may attack bacterial targets with a cross-linking mechanism [1], as, their antibacterial activities are proved much higher than monocyclic beta-lactams:;Two strategies were designed to accomplish the goal of obtaining pure bis beta-lactam diastereoisomers. The first strategy was the direct stereoselective synthetic methodology. Starting with L-L-, D-D- and L-D-meso cystines, four step reactions were performed, then, pure diastereoisomers of the 2,7-bis beta-lactam were crystallized and characterized with MALDI TOF-MS, NMR, FTIR and UV etc. Since stereo-selective mechanism favored 2,7-bis beta-lactam diastereoisomers with a trans-configuration at C3' and C4', computer simulations were carried in order to define configurations of crystalline 2,7-bis beta-lactam diastereoisomers. Simulations implemented with results of that crystalline 2(L-), 7(L-)-bis beta-lactam product favored C3·(S) and C4·(S) trans-configuration. Biological activities of crystalline 2,7-bis beta-lactams were evaluated. MIC assays demonstrated that both L-L- and D-D2,7-bis [3'-acetamido-4 '-ethoxyazetidin-2'-on-1' -yl]-4,5-dithiasuberic acids have very high antibacterial activities against both Mycobacterium and Bacillus subtilis . The second strategy was starting with S-trityl-L-cysteine to synthesize monocyclic beta-lactams: alkoxyazetidin-2'-on-1 '-yl]-propanoic 3-thiotrityl-2-[3'-acetamido-4 'acids. Since product of the monocyclic: beta-lactam was a mixture of diastereoisomers, multi-mode chromatographic methods were applied to separate these diastereoisomers. Separated diastereoisomeric components were collected, identified with the secondary ion mass spectrometer (SIMS) and distinguished with circular dichroism (CD). Then, purified monocyclic: beta-lactam precursors reacted each other by sulfur-sulfur bond linking to form bis beta-lactams: The generated 2,7-bis [3'-acetamido-4'-n-butoxyazetidin-2 '-on-1'-yl]-4,5dithiasuberic acid was also identified with the secondary ion mass spectrometer (SIMS) and UV. Based on results, both strategies successfully accomplished the goal of producing pure stereoisomers of 2,7-bis beta-lactams.
机译:Bisβ-内酰胺类:2,7-双[3'-乙酰氨基-4'-akoxyazetidin-2'-on-1'-yl] -4,5-dithiasuberic酸已被研究作为新的β-内酰胺类抗生素候选物。 2,7-双β-内酰胺的意义被解释为(1)它们具有对称的双功能结构特征,因此,它们的分子对酶底物的亲和力比其他β-内酰胺强:(2)它们可能会攻击带有β-内酰胺的细菌。交联机理[1],因为它们的抗菌活性被证明比单环β-内酰胺高得多:;设计了两种策略来实现获得纯双β-内酰胺非对映异构体的目的。第一种策略是直接立体选择性合成方法。从LL-,DD-和LD-meso胱氨酸开始,进行了四个步骤的反应,然后将2,7-bisβ-内酰胺的纯非对映异构体结晶并通过MALDI TOF-MS,NMR,FTIR和UV等进行了表征。由于立体选择机制倾向于在C3'和C4'处具有反式构型的2,7-双β-内酰胺非对映异构体,因此进行计算机模拟以定义结晶的2,7-双β-内酰胺非对映异构体的构型。用该晶体2(L-),7(L-)-双β-内酰胺产物的结果进行的模拟有利于C3·(S)和C4·(S)的反式构型。评价了结晶的2,7-双β-内酰胺的生物活性。 MIC分析表明,LL-和D-D2,7-双[3'-乙酰氨基-4'-乙氧基氮杂环丁烷-2'-上-1'-基] -4,5-二硫代丁二酸都具有很高的抗菌活性分枝杆菌和枯草芽孢杆菌。第二种策略是从S-三苯甲基-L-半胱氨酸开始,合成单环β-内酰胺:烷氧基氮杂环丁烷-2'-上-1'-基]-丙酸3-硫代三苯甲基-2- [3'-乙酰氨基-4'酸。由于单环:β-内酰胺的产物是非对映异构体的混合物,因此采用多模式色谱法分离这些非对映异构体。收集分离的非对映异构组分,用二次离子质谱仪(SIMS)鉴定,并用圆二色性(CD)区分。然后,纯化的单环:β-内酰胺前体通过硫-硫键相互反应形成双β-内酰胺:生成的2,7-双[3'-乙酰氨基-4'-n-丁氧基氮杂环丁烷-2'-对-还通过二次离子质谱仪(SIMS)和UV鉴定了1'-基] -4,5-二硫杂异丁二酸。基于结果,两种策略均成功地实现了生产2,7-双β-内酰胺的纯立体异构体的目标。

著录项

  • 作者

    Wang, Jie.;

  • 作者单位

    University of Cincinnati.;

  • 授予单位 University of Cincinnati.;
  • 学科 Chemistry Analytical.;Chemistry Biochemistry.
  • 学位 Ph.D.
  • 年度 2000
  • 页码 225 p.
  • 总页数 225
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号